ENTITY
Bioventix

Bioventix (BVXP LN)

5
Analysis
Health Care • United Kingdom
Bioventix specializes in the development and commercial supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics, particularly in clinical diagnostics and drugs of abuse testing. These antibodies are beneficial for detecting targets present at low concentrations or small molecules. The company is headquartered in Farnham, Surrey, UK, and was founded in 2003.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x